Skip to content

China

iFlytek debuts digital human creator

Chinese artificial intelligence pioneer iFlytek has unveiled a platform which simplifies and cuts the time it takes to create a virtual, or digital human from hours of video capture to just a single photograph, enabling far more natural and complex interactions. The launch of iFlytek’s “ultra-realistic digital human real-time generation technology” opens new possibilities for…

Unitree set to launch IPO in Shanghai

China’s Unitree Robotics has announced a timetable for its initial public offering in Shanghai, which is poised to value the company at more than 40 billion yuan ($5.7 billion), lifting market sentiment and setting a new benchmark for the valuation of China’s fast-growing embodied artificial intelligence sector. The offering would make Unitree the first major…

State-owned enterprises post profit increase in H1

China’s State-owned and state-holding enterprises posted year-on-year growth of 2.4 percent in total profits during the first half of the year, data from the Ministry of Finance showed on Friday. Total operating revenue of the enterprises stood at 40.24 trillion yuan ($5.96 trillion) for the January-June period, down 2.0 percent on a yearly basis. However,…

Inner Mongolia energy to cross Yangtze to power Shanghai

A cross-river project designed to facilitate power transmission from Inner Mongolia autonomous region to Shanghai was launched in the city’s Chongming district on Thursday. [Photo provided to chinadaily.com.cn] A cross-river project designed to facilitate power transmission from Inner Mongolia autonomous region to Shanghai was launched in the city’s Chongming district on Thursday, according to the…

CNRC sells 14% stake in Italian tire maker Pirelli

Marco Polo International Italy, a wholly-owned subsidiary of State-owned China National Tire and Rubber Co Ltd (CNRC), announced on Thursday that it has sold 14 percent of the share capital of Italian tire maker Pirelli & C SpA. The transaction was processed via the Transaction Confirmation Service of Euronext Milan. Following the sale, CNRC’s stake…

Tesla China announces software partnership with Doubao

Tesla China announced on Friday the rollout of a software update for Model 3, Model Y, Model S and Model X vehicles, including the integration of ByteDance’s Doubao large language model as an intelligent voice assistant. This is Tesla’s first integration of a third-party LLM into its China-market vehicles. The Doubao-powered assistant is marketed as…

Chinese asset manager buys Swiss sportswear firm

A Mammut store is pictured in Nanjing, Jiangsu province, on June 24. [Photo/VCG] Chinese alternative asset manager CPE has agreed to acquire Mammut Sports Group AG from Jacobs Capital, as the Swiss outdoor performance brand looks to accelerate growth worldwide. The transaction, announced Thursday, marks the end of a three-year transformation phase under Jacobs Capital,…

Tesla China denies spin-off reports

Visitors check out a Tesla vehicle at the 27th China (Kunming) International Automobile Expo, Yunnan province, on July 23. [Photo/VCG] Tesla China has dismissed as “untrue” recent media reports that the company is considering selling or spinning off its China operations to facilitate a potential merger with SpaceX. The reports, which cited unnamed sources, suggested…

Hong Kong asset manager becomes member of Global Philanthropic Alliance

Quantum Capital Management Limited has joined Promote Giving, a worldwide philanthropic coalition of top investment firms, making it the first asset manager based in China’s Hong Kong Special Administrative Region to secure membership and marking a milestone for structured charitable giving in Hong Kong of China’s cross-border asset management sector. Regulated by the securities and…

Chinese drug candidate secures FDA fast track status

YN003 injection, an innovative therapy built on China’s self-developed active targeted nano drug delivery platform, has been granted Fast Track designation by the US Food and Drug Administration for treating adult glioma patients, including those with glioblastoma. The blood-brain barrier (BBB) stands as a core bottleneck for brain tumor treatments. It blocks most anti-tumor drugs…